Collegium Pharmaceutical (COLL) Cash & Equivalents (2014 - 2026)
Collegium Pharmaceutical (COLL) recorded Cash & Equivalents of $129.47 million in Q2 2026, up 10.3% from $117.35 million a year earlier but down 51.8% from the prior quarter.
Collegium Pharmaceutical (COLL) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Collegium Pharmaceutical reported Cash & Equivalents of $231.25 million, up 227.7% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 5.8% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $70.57 million in FY2024 (-70.5%), $238.95 million in FY2023 (+37.6%), $173.69 million in FY2022 (-6.8%) and $186.43 million in FY2021 (+7.1%).
- Quarterly Cash & Equivalents has ranged from $38.96 million in Q3 2024 to $283.75 million in Q2 2023 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 57.1% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 285.3% in Q3 2025, against a decline of 84.9% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $268.65 million (Q1 2026), $231.25 million (Q4 2025) and $150.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Collegium Pharmaceutical | 709.11 Mn | -514.65 Mn | 110.29 Mn | 129.47 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.47 Mn |
| Mar 31, 2026 | 268.65 Mn |
| Dec 31, 2025 | 231.25 Mn |
| Sep 30, 2025 | 150.10 Mn |
| Jun 30, 2025 | 117.35 Mn |
| Mar 31, 2025 | 96.19 Mn |
| Dec 31, 2024 | 70.57 Mn |
| Sep 30, 2024 | 38.96 Mn |
| Jun 30, 2024 | 172.89 Mn |
| Mar 31, 2024 | 228.61 Mn |
| Dec 31, 2023 | 238.95 Mn |
| Sep 30, 2023 | 258.53 Mn |
| Jun 30, 2023 | 283.75 Mn |
| Mar 31, 2023 | 269.48 Mn |
| Dec 31, 2022 | 173.69 Mn |
| Sep 30, 2022 | 134.13 Mn |
| Jun 30, 2022 | 122.72 Mn |
| Mar 31, 2022 | 106.70 Mn |
| Dec 31, 2021 | 186.43 Mn |
| Sep 30, 2021 | 193.24 Mn |
Collegium Pharmaceutical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=COLL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "COLL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=COLL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();